Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/3580EB9B.svg?ark=w1%2F20260515%2F3580EB9B)](https://nobleid.org/work/w1/20260515/3580EB9B)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors